In recent years, the landscape of non-hormonal drugs for VMS has expanded significantly, offering alternatives for women who are contraindicated or prefer not to use hormone therapy (HT). This module ...

Fezolinetant (Veozah®) and elinzanetant (Lynkuet®) represent significant advancements in the non-hormonal management of moderate to severe VMS. The effectiveness of both these therapies is based on their unique and targeted ...

Understanding the evidence base for new therapies is critical for informed clinical practice. This module outlines the key efficacy and safety results from the phase 3 clinical trials of fezolinetant ...

This module presents a clinical case study to demonstrate the practical application of emerging non-hormonal therapies in a patient with VMS. It emphasizes how new options can address unmet needs ...

This streamlined program designed to translate complex lipid science into actionable Canadian primary care. Participants will progress from understanding the biological foundations of atherosclerosis to mastering the latest national guidelines ...

Master the complexities of thyroid care with these 5-minute “Clinical Snaps.” Designed for the busy Canadian practitioner, this series moves beyond the basics to tackle the “grey zones” of diagnosis ...

This webinar explores a practical ethical framework for understanding how AI is reshaping healthcare, with a focus on clinical practice and clinical documentation. Using the SPECTRAILS model, the session examines ...

This short microlearning program is designed to provide healthcare professionals with essential knowledge and strategies to address the challenges of polypharmacy in chronic pain management. It focuses on minimizing risks, ...

This module reviews key evidence shaping current approaches to subclinical hypothyroidism and highlights important updates in thyroid dysfunction. Through a timeline and labeled graphic, learners gain a clear overview of ...